Cargando…

A case report of ABPA, cystic fibrosis and asthma treated with omalizumab

Detalles Bibliográficos
Autores principales:	Mazza, JA, Lewis, J, Gooyers, Tracy
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	World Allergy Organization 2015
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4406118/ http://dx.doi.org/10.1186/1939-4551-8-S1-A86

Ejemplares similares

An ALARMINg Type 2 Response in Cystic Fibrosis—The Key to Understanding ABPA?
por: Bojanowski, Christine M., et al.
Publicado: (2023)

Omalizumab treatment of moderate to severe asthma in the adolescent and pediatric population
por: O’Quinn, John, et al.
Publicado: (2014)

Bronchial asthma with ABPA presenting as PTE
por: Azad, Chandrika, et al.
Publicado: (2013)

Specific antibodies to recombinant allergens of Aspergillus fumigatus in cystic fibrosis patients with ABPA
por: Kurup, Viswanath P, et al.
Publicado: (2006)

Xolair® (omalizumab) enrollment in a tertiary care allergy and asthma clinic in Canada
por: Cameron, Jodi, et al.
Publicado: (2014)

Omalizumab is effective in the treatment of difficult-to-treat chronic spontaneous urticaria
por: Forgie, Jennifer, et al.
Publicado: (2014)

Follow-up of asthma control and quality of life after discontinuation of omalizumab in severe asthmatic patients
por: Nayci, Sibel, et al.
Publicado: (2015)

Reduced exacerbation frequency and prednisone dose in patients with ABPA and asthma treated with dupilumab
por: van der Veer, Tjeerd, et al.
Publicado: (2021)

Efficacy and safety of the use of omalizumab in a patient with difficult-to-control severe asthma and antiphospholipid antibody syndrome
por: Villela, Rosangela, et al.
Publicado: (2015)

The observed incidence of anaphylaxis and serum sickness in patients receiving omalizumab in a tertiary allergy and asthma clinic in Canada
por: MacRae, Megan, et al.
Publicado: (2014)

Omalizumab in chronic spontaneous urticaria (CSU): experience in three cases
por: Valle, Solange Oliveira Rodrigues, et al.
Publicado: (2015)

Efficacy of Omalizumab therapy in a case of severe atopic dermatitis
por: Barrios, Jonathan Lacombe, et al.
Publicado: (2011)

Asthma diagnosis and treatment – 1015. Improvements in lung function in an indian population with IgE mediated asthma receiving omalizumab in a real-world setting
por: Guleria, Randeep, et al.
Publicado: (2013)

279 Near-Fatal Asthma Treated with Omalizumab
por: Contreras Contreras, Elvia Angelica, et al.
Publicado: (2012)

Use of Omalizumab to treat a nine-year old, with steroid-dependent, allergic asthma, adrenal insufficiency and vertebral compression fractures due to steroid induced severe osteoporosis
por: Ring, Alicia, et al.
Publicado: (2011)

Effects of omalizumab on chronic urticaria not responding to recommended therapy
por: Hébert, Jacques, et al.
Publicado: (2012)

Measured depth of subcutaneous tissue on posterolateral arm of omalizumab patients
por: Potts, Ryan, et al.
Publicado: (2012)

Omalizumab in allergic bronchopulmonary aspergillosis in patients with cystic fibrosis
por: Ashkenazi, Moshe, et al.
Publicado: (2018)

Microevolution of Pseudomonas aeruginosa in cystic fibrosis lungs
por: Cramer, Nina, et al.
Publicado: (2014)

Health outcomes, education, healthcare delivery and quality – 3038: The relation of sTRAIL levels and quality of life in omalizumab using severe persistent allergic asthma patients
por: Yalcin, Arzu Didem, et al.
Publicado: (2013)

Health outcomes, education, healthcare delivery and quality – 3052. IL-17, IL-18, TGF-beta and GMCSF levels in patients with allergic asthma: Its relation to omalizumab treatment
por: Yalcin, Arzu Didem, et al.
Publicado: (2013)

Omalizumab in allergic bronchopulmonary aspergillosis in patients with cystic fibrosis [Erratum]
Publicado: (2018)

274 Vasculitic Urticaria Treated with Omalizumab. Case Report
por: Ramírez Del Pozo, María Elena, et al.
Publicado: (2012)

Review of current and future therapeutics in ABPA
por: Lewington-Gower, Elisa, et al.
Publicado: (2021)

Basophil Activation Test With Aspergillus Molecules: The Case for ABPA
por: Michel, Moïse, et al.
Publicado: (2022)

Differential response to biologics in a patient with severe asthma and ABPA: a role for dupilumab?
por: Mümmler, Carlo, et al.
Publicado: (2020)

Misdiagnosis of persistent asthma of a patient suffering from acute bronchopulmonary aspergillosis (ABPA)
por: Abuzneid, Yousef S., et al.
Publicado: (2021)

Abstracts from the 23rd Italian congress of Cystic Fibrosis and the 13th National congress of Cystic Fibrosis Italian Society: Naples, Italy. 22-25 November 2017
por: Bevivino, Annamaria, et al.
Publicado: (2018)

Abstracts from the 25th Italian Congress of Cystic Fibrosis and the 15th National Congress of Cystic Fibrosis Italian Society: Assago, Milan. 10 - 12 October 2019
Publicado: (2020)

Abstracts from the 24th Congress of the Italian Society of Cystic Fibrosis and the 14th National Congress of Cystic Fibrosis Italian Society: Salerno, Italy. 8 -10 November 2018
Publicado: (2019)

Omalizumab in symptomatic therapy of laryngeal oedema and urticaria attacts in a patient with post operative pulmonary carsinoid tumor
por: Yalcin, Arzu Didem, et al.
Publicado: (2015)

Comprehensive transcriptome analysis of peripheral blood unravels key lncRNAs implicated in ABPA and asthma
por: Huang, Chen, et al.
Publicado: (2021)

Allergic Bronchopulmonary Aspergillosis (ABPA) Diagnosis Missed in the Context of Asthma Exacerbation Due to Medication Nonadherence
por: Rasheed, Waqas, et al.
Publicado: (2022)

A regulatory SNP modifies cystic fibrosis by disrupting NFκB complex binding on FAS
por: Awah, Chidiebere U, et al.
Publicado: (2015)

Connexin 37 and Connexin 43 genotypes in correlation to cytokines in induced sputum and blood in cystic fibrosis (CF)
por: Ludwig, M, et al.
Publicado: (2014)

Omalizumab for Severe Asthma: Beyond Allergic Asthma
por: Loureiro, C. C., et al.
Publicado: (2018)

COVID‐19 in a patient with severe asthma treated with Omalizumab
por: Lommatzsch, Marek, et al.
Publicado: (2020)

Severe asthma and the omalizumab option
por: Miller, Christopher WT, et al.
Publicado: (2008)

Omalizumab treatment in brittle asthma
por: Skiepko, Roman, et al.
Publicado: (2014)

The Proceedings of the 16th Italian Convention of Investigators in Cystic Fibrosis: Verona, Italy. 22-24 November 2018
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ub3k13476b0djtvl3rc3fuopok